US Stock MarketDetailed Quotes

DRIO DarioHealth

Watchlist
  • 1.130
  • +0.090+8.65%
Close Oct 4 16:00 ET
  • 1.160
  • +0.030+2.65%
Post 20:02 ET
33.93MMarket Cap-965P/E (TTM)

DarioHealth Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
1.67%6.26M
-18.50%5.76M
-26.41%20.35M
-46.89%3.62M
-46.74%3.52M
-0.50%6.15M
-12.33%7.07M
34.82%27.66M
12.96%6.81M
17.34%6.61M
Operating revenue
1.67%6.26M
-18.50%5.76M
-26.41%20.35M
-46.89%3.62M
-46.74%3.52M
-0.50%6.15M
-12.33%7.07M
34.82%27.66M
12.96%6.81M
17.34%6.61M
Cost of revenue
-14.20%3.5M
-14.67%3.33M
-20.18%14.37M
-14.55%3.48M
-39.48%2.91M
-19.17%4.08M
-4.30%3.9M
8.77%18M
-25.60%4.08M
0.04%4.81M
Gross profit
32.88%2.76M
-23.23%2.43M
-38.02%5.98M
-95.17%132K
-66.11%610K
82.25%2.07M
-20.52%3.17M
143.63%9.66M
398.54%2.73M
117.92%1.8M
Operating expense
17.73%18.95M
30.25%20.29M
-6.46%62.17M
22.19%14.35M
-1.33%16.16M
-12.97%16.09M
-21.56%15.58M
-17.39%66.47M
-47.14%11.74M
-29.80%16.37M
Selling and administrative expenses
11.64%12.14M
31.06%13.65M
-10.45%41.93M
45.85%10.15M
-9.33%10.49M
-24.27%10.87M
-25.26%10.41M
-25.97%46.82M
-58.81%6.96M
-35.07%11.57M
-Selling and marketing expense
10.40%7.13M
8.99%6.91M
-21.56%23.79M
17.91%4.62M
-15.96%6.36M
-30.52%6.46M
-33.51%6.34M
-23.63%30.32M
-67.95%3.92M
-29.22%7.57M
-General and administrative expense
13.44%5.01M
65.44%6.74M
9.99%18.14M
81.88%5.53M
3.23%4.13M
-12.79%4.41M
-7.37%4.07M
-29.91%16.49M
-34.86%3.04M
-43.86%4M
Research and development costs
30.41%6.81M
28.60%6.64M
3.05%20.25M
-12.25%4.2M
17.95%5.67M
26.23%5.22M
-12.86%5.17M
14.11%19.65M
-10.05%4.78M
-12.77%4.8M
Operating profit
-15.49%-16.19M
-43.90%-17.86M
1.09%-56.19M
-57.77%-14.22M
-6.68%-15.55M
19.22%-14.02M
21.82%-12.41M
25.73%-56.81M
58.41%-9.01M
35.23%-14.57M
Net non-operating interest income expense
200.62%2.58M
7.83%-530K
156.18%1.22M
125.96%421K
82.44%-186K
-281.70%-2.57M
-2,513.64%-575K
-5,342.50%-2.18M
-10,037.50%-1.62M
-2,025.45%-1.06M
Non-operating interest income
----
16.42%390K
269.17%1.87M
69.06%470K
----
----
8,275.00%335K
1,050.00%506K
3,375.00%278K
----
Non-operating interest expense
----
----
--0
----
----
----
----
--1.88M
----
----
Total other finance cost
-200.62%-2.58M
1.10%920K
-20.07%645K
104.17%49K
-82.44%186K
281.70%2.57M
3,400.00%910K
860.71%807K
0.00%24K
2,025.45%1.06M
Other net income (expense)
5,732.91%9.22M
-37.32%-4.4M
78.46%-427K
818.18%158K
-1,542.05%-3.2M
-1,660.63%-1.98M
Gain on sale of security
----
5,732.91%9.22M
-37.32%-4.4M
78.46%-427K
----
----
818.18%158K
-1,542.05%-3.2M
-1,660.63%-1.98M
----
Income before tax
17.94%-13.61M
28.51%-9.17M
4.54%-59.36M
-12.75%-14.22M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.95%-62.19M
41.48%-12.61M
30.35%-15.63M
Income tax
0
-1.99M
1,500.00%64K
2,033.33%64K
0
0
0
-87.50%4K
-90.63%3K
0
Net income
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.98%-62.19M
41.55%-12.62M
30.35%-15.63M
Net income continuous Operations
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.98%-62.19M
41.55%-12.62M
30.35%-15.63M
Minority interest income
Net income attributable to the parent company
17.94%-13.61M
44.05%-7.18M
4.45%-59.43M
-13.23%-14.29M
-0.64%-15.73M
8.00%-16.59M
19.42%-12.83M
18.98%-62.19M
41.55%-12.62M
30.35%-15.63M
Preferred stock dividends
-614.84%-8.71M
2.03M
148.57%4.08M
360.75%1.22M
137.25%1.17M
290.53%1.69M
1.64M
265K
1.23%494K
Other preferred stock dividends
Net income attributable to common stockholders
73.17%-4.9M
28.19%-9.21M
0.51%-63.51M
-20.37%-15.51M
-4.82%-16.9M
1.00%-18.28M
21.64%-12.83M
16.84%-63.84M
35.80%-12.88M
29.68%-16.13M
Basic earnings per share
86.21%-0.08
55.56%-0.2
24.02%-1.93
21.15%-0.41
23.44%-0.49
21.62%-0.58
-160.81%-0.45
37.59%-2.54
52.29%-0.52
45.76%-0.64
Diluted earnings per share
86.21%-0.08
55.56%-0.2
24.02%-1.93
21.15%-0.41
23.44%-0.49
21.62%-0.58
-160.81%-0.45
37.59%-2.54
52.29%-0.52
45.76%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 1.67%6.26M-18.50%5.76M-26.41%20.35M-46.89%3.62M-46.74%3.52M-0.50%6.15M-12.33%7.07M34.82%27.66M12.96%6.81M17.34%6.61M
Operating revenue 1.67%6.26M-18.50%5.76M-26.41%20.35M-46.89%3.62M-46.74%3.52M-0.50%6.15M-12.33%7.07M34.82%27.66M12.96%6.81M17.34%6.61M
Cost of revenue -14.20%3.5M-14.67%3.33M-20.18%14.37M-14.55%3.48M-39.48%2.91M-19.17%4.08M-4.30%3.9M8.77%18M-25.60%4.08M0.04%4.81M
Gross profit 32.88%2.76M-23.23%2.43M-38.02%5.98M-95.17%132K-66.11%610K82.25%2.07M-20.52%3.17M143.63%9.66M398.54%2.73M117.92%1.8M
Operating expense 17.73%18.95M30.25%20.29M-6.46%62.17M22.19%14.35M-1.33%16.16M-12.97%16.09M-21.56%15.58M-17.39%66.47M-47.14%11.74M-29.80%16.37M
Selling and administrative expenses 11.64%12.14M31.06%13.65M-10.45%41.93M45.85%10.15M-9.33%10.49M-24.27%10.87M-25.26%10.41M-25.97%46.82M-58.81%6.96M-35.07%11.57M
-Selling and marketing expense 10.40%7.13M8.99%6.91M-21.56%23.79M17.91%4.62M-15.96%6.36M-30.52%6.46M-33.51%6.34M-23.63%30.32M-67.95%3.92M-29.22%7.57M
-General and administrative expense 13.44%5.01M65.44%6.74M9.99%18.14M81.88%5.53M3.23%4.13M-12.79%4.41M-7.37%4.07M-29.91%16.49M-34.86%3.04M-43.86%4M
Research and development costs 30.41%6.81M28.60%6.64M3.05%20.25M-12.25%4.2M17.95%5.67M26.23%5.22M-12.86%5.17M14.11%19.65M-10.05%4.78M-12.77%4.8M
Operating profit -15.49%-16.19M-43.90%-17.86M1.09%-56.19M-57.77%-14.22M-6.68%-15.55M19.22%-14.02M21.82%-12.41M25.73%-56.81M58.41%-9.01M35.23%-14.57M
Net non-operating interest income expense 200.62%2.58M7.83%-530K156.18%1.22M125.96%421K82.44%-186K-281.70%-2.57M-2,513.64%-575K-5,342.50%-2.18M-10,037.50%-1.62M-2,025.45%-1.06M
Non-operating interest income ----16.42%390K269.17%1.87M69.06%470K--------8,275.00%335K1,050.00%506K3,375.00%278K----
Non-operating interest expense ----------0------------------1.88M--------
Total other finance cost -200.62%-2.58M1.10%920K-20.07%645K104.17%49K-82.44%186K281.70%2.57M3,400.00%910K860.71%807K0.00%24K2,025.45%1.06M
Other net income (expense) 5,732.91%9.22M-37.32%-4.4M78.46%-427K818.18%158K-1,542.05%-3.2M-1,660.63%-1.98M
Gain on sale of security ----5,732.91%9.22M-37.32%-4.4M78.46%-427K--------818.18%158K-1,542.05%-3.2M-1,660.63%-1.98M----
Income before tax 17.94%-13.61M28.51%-9.17M4.54%-59.36M-12.75%-14.22M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.95%-62.19M41.48%-12.61M30.35%-15.63M
Income tax 0-1.99M1,500.00%64K2,033.33%64K000-87.50%4K-90.63%3K0
Net income 17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.98%-62.19M41.55%-12.62M30.35%-15.63M
Net income continuous Operations 17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.98%-62.19M41.55%-12.62M30.35%-15.63M
Minority interest income
Net income attributable to the parent company 17.94%-13.61M44.05%-7.18M4.45%-59.43M-13.23%-14.29M-0.64%-15.73M8.00%-16.59M19.42%-12.83M18.98%-62.19M41.55%-12.62M30.35%-15.63M
Preferred stock dividends -614.84%-8.71M2.03M148.57%4.08M360.75%1.22M137.25%1.17M290.53%1.69M1.64M265K1.23%494K
Other preferred stock dividends
Net income attributable to common stockholders 73.17%-4.9M28.19%-9.21M0.51%-63.51M-20.37%-15.51M-4.82%-16.9M1.00%-18.28M21.64%-12.83M16.84%-63.84M35.80%-12.88M29.68%-16.13M
Basic earnings per share 86.21%-0.0855.56%-0.224.02%-1.9321.15%-0.4123.44%-0.4921.62%-0.58-160.81%-0.4537.59%-2.5452.29%-0.5245.76%-0.64
Diluted earnings per share 86.21%-0.0855.56%-0.224.02%-1.9321.15%-0.4123.44%-0.4921.62%-0.58-160.81%-0.4537.59%-2.5452.29%-0.5245.76%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data